OPEN END TURBO SHORT - DIASORIN Stock

DE000MB4YAX6

Market Closed - Börse Stuttgart 03:23:28 2024-05-28 am EDT
0.9 ^EUR	+4.65%

Current month	-37.23%
1 month	-36.30%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DIASORIN S.P.A.

Latest news about DIASORIN S.P.A.

Indices flat; Newlat runs after Princes acquisition.	May. 27	AN
Citadel Advisors moves on Saipem and Biesse.	May. 21	AN
DiaSorin takes over shares for more than EUR8 million	May. 20	AN
Ex-dividend day for final dividend	May. 19	FA

More news

Quotes 5-day view

Date	Price	Change
24-05-28	0.9	+4.65%
24-05-27	0.86	-6.52%
24-05-24	0.92	-6.12%
24-05-23	0.98	+16.67%
24-05-22	0.84	+3.70%

Delayed Quote Börse Stuttgart

Last update May 28, 2024 at 03:23 am EDT

More quotes

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	PUT
Underlying	DIASORIN S.P.A.
Issuer	Morgan Stanley
WKN	MB4YAX
ISIN	DE000MB4YAX6
Date issued	2023-03-29
Strike	107.3 €
Maturity	Unlimited
Parity	10 : 1
Emission price	1.12 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	2.72 €
Lowest since issue	0.41 €

Company Profile

DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2023, the group had 10 production sites located in Italy, the United States (6), Canada, Germany, and the United Kingdom.

Sector

More about the company

Ratings for DiaSorin S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Consensus: DiaSorin S.p.A.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

98.62 EUR

Average target price

100.1 EUR

Spread / Average Target

+1.48%

Consensus